Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer

ABSTRACT: Here we analysed the immunopeptidomes of 6 HLA-A2-positive triple negative breast cancer (TNBC) samples by nano-ultra performance liquid chromatography tandem mass spectrometry (nUPLC-MS2).

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Breast

DISEASE(S): Triple-receptor Negative Breast Cancer

SUBMITTER: Nicola Ternette  

LAB HEAD: Dr Nicola Maria Nathalie Ternette

PROVIDER: PXD009738 | Pride | 2018-06-29

REPOSITORIES: Pride